Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Chemical Reviews

• Publication date

  2014-02-26

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/cr4003984PMID 24313284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis Assay

  2013cited by this paper
• Antibacterial action of quinolones: from target to network.

  2013cited by this paper
• Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.

  2013cited by this paper
• Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.

  2013cited by this paper
• Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI

  2013cited by this paper
• Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

  2013cited by this paper
• Novel DNA gyrase inhibitors: microbiological characterisation of pyrrolamides.

  2013cited by this paper
• Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines.

  2013cited by this paper
• Mapping the spectrum of conformational states of the DNA- and C-gates in Bacillus subtilis gyrase.

  2013cited by this paper
• Structure-activity relationship of flavonoids on their anti-Escherichia coli activity and inhibition of DNA gyrase.

  2013cited by this paper
• Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis.

  2013cited by this paper
• Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.

  2013cited by this paper
• Structural insight into negative DNA supercoiling by DNA gyrase, a bacterial type 2A DNA topoisomerase

  2013cited by this paper
• Synthesis, Structure and Antibacterial Activity of Potent DNA Gyrase Inhibitors: N′-Benzoyl-3-(4-Bromophenyl)-1H-Pyrazole-5-Carbohydrazide Derivatives

  2013cited by this paper
• Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons

  2013cited by this paper
• An improved assay for the detection of alterations in bacterial DNA supercoiling in vivo.

  2013cited by this paper
• Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.

  2013cited by this paper
• Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases.

  2013cited by this paper
• Antibacterial activity of head-to-head bis-benzimidazoles.

  2013cited by this paper
• First- and second-generation quinolone antibacterial drugs interacting with zinc(II): structure and biological perspectives.

  2013cited by this paper
• Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity.

  2013cited by this paper
• Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.

  2013cited by this paper
• Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases

  2013cited by this paper
• Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance

  2013cited by this paper
• A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα.

  2013cited by this paper
• Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity.

  2013cited by this paper
• Evaluation of WO2012177707 and WO2012097269: Vertex's phosphate prodrugs of gyrase and topoisomerase antibacterial agents

  2013cited by this paper
• Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.

  2013cited by this paper
• In Vitro Activity of Novel Gyrase Inhibitors against a Highly Resistant Population of Pseudomonas aeruginosa

  2013cited by this paper
• Design and synthesis of peptides from bacterial ParE toxin as inhibitors of topoisomerases.

  2012cited by this paper
• Symmetric bis-benzimidazoles are potent anti-staphylococcal agents with dual inhibitory mechanisms against DNA gyrase.

  2012cited by this paper
• Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors.

  2012cited by this paper
• Structure-based discovery of substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors.

  2012cited by this paper
• Amycolamicin: a novel broad-spectrum antibiotic inhibiting bacterial topoisomerase.

  2012cited by this paper
• YcaO domains utilize ATP to activate amide backbones during peptide cyclodehydrations

  2012cited by this paper
• The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action

  2012cited by this paper
• Structural and functional dissection of aminocoumarin antibiotic biosynthesis: a review

  2012cited by this paper
• A Common Origin for the Bacterial Toxin-Antitoxin Systems parD and ccd, Suggested by Analyses of Toxin/Target and Toxin/Antitoxin Interactions

  2012cited by this paper
• Inhibition of human topoisomerases I and II by simocyclinone D8.

  2012cited by this paper
• Bacterial DNA replication enzymes as targets for antibacterial drug discovery

  2012cited by this paper
• Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities.

  2012cited by this paper
• The role of enzymology in a structure-based drug discovery program: bacterial DNA gyrase.

  2012cited by this paper
• Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.

  2012cited by this paper
• Overuse of health care services in the United States: an understudied problem.

  2012cited by this paper
• Alternative interactions define gyrase specificity in the CcdB family

  2012cited by this paper
• Targeting DNA topoisomerase I with non-camptothecin poisons.

  2012cited by this paper
• Practical and innate C–H functionalization of heterocycles

  2012cited by this paper
• Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.

  2012cited by this paper
• Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases.

  2011cited by this paper
• Pyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial Agents

  2011cited by this paper
• Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy.

  2011cited by this paper
• Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.

  2011cited by this paper
• ATP-binding site of bacterial enzymes as a target for antibacterial drug design.

  2011cited by this paper
• Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates.

  2011cited by this paper
• Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.

  2011cited by this paper
• A High-Throughput Fluorescence Polarization Assay for Inhibitors of Gyrase B

  2011cited by this paper
• Exploiting bacterial DNA gyrase as a drug target: current state and perspectives

  2011cited by this paper
• Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.

  2011cited by this paper
• Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitors.

  2011cited by this paper
• Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity.

  2011cited by this paper
• Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.

  2011cited by this paper
• A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.

  2011cited by this paper
• Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases.

  2011cited by this paper
• An artificial pathway to 3,4-dihydroxybenzoic acid allows generation of new aminocoumarin antibiotic recognized by catechol transporters of E. coli.

  2011cited by this paper
• N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

  2011cited by this paper
• Selenophene-containing inhibitors of type IIA bacterial topoisomerases.

  2011cited by this paper
• A high-throughput assay for DNA topoisomerases and other enzymes, based on DNA triplex formation.

  2010cited by this paper
• Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase

  2010cited by this paper
• Coumabiocins A-F, aminocoumarins from an organic extract of Streptomyces sp. L-4-4.

  2010cited by this paper
• The use of divalent metal ions by type II topoisomerases.

  2010cited by this paper
• Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90.

  2010cited by this paper
• Type IIA topoisomerase inhibition by a new class of antibacterial agents

  2010cited by this paper
• Target-directed synthesis of antibacterial drug candidate GSK966587.

  2010cited by this paper
• New quinolone antibiotics: a survey of the literature from 2005 to 2010

  2010cited by this paper
• Interaction specificity, toxicity and regulation of a paralogous set of ParE/RelE‐family toxin–antitoxin systems

  2010cited by this paper
• Functional analysis of genes for benzoate metabolism in the albicidin biosynthetic region of Xanthomonas albilineans

  2010cited by this paper
• Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases

  2010cited by this paper
• ATPase inhibitors of heat-shock protein 90, second season.

  2010cited by this paper
• Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

  2010cited by this paper
• DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

  2010cited by this paper
• A Homogeneous, High-Throughput Fluorescence Anisotropy-Based DNA Supercoiling Assay

  2010cited by this paper
• In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B.

  2010cited by this paper
• Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

  2010cited by this paper
• A conserved mode of protein recognition and binding in a ParD-ParE toxin-antitoxin complex.

  2010cited by this paper
• Reactivity of clerocidin towards adenine: implications for base-modulated DNA damage.

  2009cited by this paper
• Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms

  2009cited by this paper
• The clinical consequences of antimicrobial resistance.

  2009cited by this paper
• Mapping Simocyclinone D8 Interaction with DNA Gyrase: Evidence for a New Binding Site on GyrB

  2009cited by this paper
• Antibiotics for Emerging Pathogens

  2009cited by this paper
• Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents.

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase

  2009cited by this paper
• New inhibitors of bacterial topoisomerase GyrA/ParC subunits.

  2009cited by this paper
• On the divalent metal ion dependence of DNA cleavage by restriction endonucleases of the EcoRI family.

  2009cited by this paper
• Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.

  2009cited by this paper
• DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.

  2009cited by this paper
• In Vivo and In Vitro Patterns of the Activity of Simocyclinone D8, an Angucyclinone Antibiotic from Streptomyces antibioticus

  2009cited by this paper
• Development of a liquid chromatography/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa.

  2009cited by this paper
• Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.

  2009cited by this paper
• Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates.

  2009cited by this paper

• Current Scenario and Various Mechanisms of Antimicrobial Resistance in Neisseria gonorrhoeae – A Comprehensive Review

  2025cites this paper
• Novel fluoroquinolone-based organic salts: Pioneering solutions in targeting bacterial DNA gyrase

  2025cites this paper
• ZAB260: A Novel and potent antibacterial agent targeting DNA gyrase

  2025cites this paper
• Recent Advances in Pyrimidine-Based Drugs

  2024cites this paper
• Dynamic Profiling and Binding Affinity Prediction of NBTI Antibacterials against DNA Gyrase Enzyme by Multidimensional Machine Learning and Molecular Dynamics Simulations

  2024cites this paper
• Chrysin based pyrimidine-piperazine hybrids: design, synthesis, in vitro antimicrobial and in silico E. coli topoisomerase II DNA gyrase efficacy

  2023cites this paper
• Novel 4,5-dibromo-N-phenyl-1H-pyrrole-2-carboxamide Hybrids as Promising DNA Gyrase Inhibitors: Design, Synthesis and Antimicrobial Evaluation

  2023cites this paper
• Recent Development of DNA Gyrase Inhibitors: An Update.

  2023cites this paper
• Focused Insights Into Emerging Pyrimidine Molecules with Multifarious Anti-Infective Perspectives

  2023cites this paper
• The roles of membrane permeability and efflux pumps in the toxicity of bisphenol S analogues (2,4-bisphenol S and bis-(3-allyl-4-hydroxyphenyl) sulfone) to Escherichia coli K12.

  2023cites this paper
• Computational Analysis on Molecular Stability and Binding Affinity of 3-(Aminothiazolyl)Quinolone Derivative as Multitargeting Antibacterial Agents through Ab Initio Methods and Molecular Docking

  2023cites this paper
• On drug discovery against infectious diseases and academic medicinal chemistry contributions

  2022cites this paper
• New 1,2,4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity

  2022cites this paper
• Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria.

  2021cites this paper
• Novel Bacterial Topoisomerase Inhibitors (NBTIs) – A comprehensive review

  2021cites this paper
• Design, Synthesis, and Biological Evaluation of Novel Pyrimido[4,5-b]indole Derivatives Against Gram-Negative Multidrug-Resistant Pathogens.

  2021cites this paper
• Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with In Vivo Efficacy against MRSA.

  2021cites this paper
• Non-quinolone Inhibitors of the Bacterial DNA Gyrase

  2021cites this paper
• New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.

  2021cites this paper
• Solid-Phase Synthesis and Biological Evaluation of Piperazine-Based Novel Bacterial Topoisomerase Inhibitors.

  2021cites this paper
• Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)

  2020cites this paper
• Recent advances in DNA gyrase-targeted antimicrobial agents.

  2020cites this paper
• Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.

  2020cites this paper
• Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.

  2020cites this paper
• Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation

  2020cites this paper
• Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus.

  2020cites this paper
• Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation

  2020cites this paper
• Structural and mechanistic analysis of ATPase inhibitors targeting mycobacterial DNA gyrase

  2020cites this paper
• Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.

  2020cites this paper
• Fic Proteins Inhibit the Activity of Topoisomerase IV by AMPylation in Diverse Bacteria

  2020cites this paper
• Crystal structure of the 65-kilodalton amino-terminal fragment of DNA topoisomerase I from the gram-positive model organism Streptococcus mutans.

  2019cites this paper
• Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine–Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors

  2019cites this paper
• Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity

  2019cites this paper
• Pharmacophore modeling, atom based 3D-QSAR, molecular docking and molecular dynamics studies on Escherichia coli ParE inhibitors

  2019cites this paper
• Synthesis, molecular docking and antimicrobial activity of new fused pyrimidine and pyridine derivatives.

  2019cites this paper
• Bioactivity Profile of the Diterpene Isosteviol and its Derivatives

  2019cites this paper
• 1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG Inhibition.

  2019cites this paper
• Iron-Promoted Intramolecular Cascade Cyclization for the Synthesis of Selenophene-fused, Quinoline-based Heteroacenes.

  2019cites this paper
• Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies.

  2019cites this paper
• Topoisomerases as anticancer targets.

  2018cites this paper
• DNA Topoisomerases as Targets for Antibacterial Agents.

  2018cites this paper
• Design, synthesis, and biological evaluation of 1‐ethyl‐3‐(thiazol‐2‐yl)urea derivatives as Escherichia coli DNA gyrase inhibitors

  2018cites this paper
• Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

  2018cites this paper
• Recent progress in the discovery and development of DNA gyrase B inhibitors.

  2018cites this paper
• Efficient preparation of β-hydroxy aspartic acid and its derivatives

  2018cites this paper
• Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.

  2018cites this paper
• Mycobacterium tuberculosis inhibitors: action and resistance

  2018cites this paper
• Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site

  2018cites this paper
• Synthesis and Evaluation of N‐Phenylpyrrolamides as DNA Gyrase B Inhibitors

  2018cites this paper
• New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV.

  2018cites this paper
• Bacterial GyrB ATPase domain in complex with a chemical fragment

  2018cites this paper
• Non-quinolone Topoisomerase Inhibitors

  2018cites this paper
• Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.

  2017cites this paper
• Structure-based design of novel combinatorially generated NBTIs as potential DNA gyrase inhibitors against various Staphylococcus aureus mutant strains.

  2017cites this paper
• Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents.

  2017cites this paper
• Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors.

  2017influential citation
• Four Ways to Skin a Cat: Inhibition of Bacterial Topoisomerases Leading to the Clinic

  2017cites this paper
• Stereo-Electronic, Molecular Connectivity, and Geometric Configuration Approaches towards Designing Antibacterial Agents from 1, 3, 4-Thiadiazole as the Starting Molecular Template

  2017cites this paper
• Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase

  2017cites this paper
• The role of DNA gyrase in illegitimate recombination

  2017cites this paper
• Total Syntheses of Cystobactamids and Structural Confirmation of Cystobactamid 919-2.

  2017cites this paper
• Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.

  2017cites this paper
• Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.

  2017cites this paper
• Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.

  2017cites this paper
• An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor

  2016cites this paper
• A simplified protocol for high-yield expression and purification of bacterial topoisomerase I.

  2016cites this paper
• Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases.

  2016cites this paper
• Chromanyl–isoxazolidines as Antibacterial agents: Synthesis, Biological Evaluation, Quantitative Structure Activity Relationship, and Molecular Docking Studies

  2016cites this paper
• Targeting bacterial topoisomerases: how to counter mechanisms of resistance.

  2016cites this paper
• New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase.

  2016cites this paper
• Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.

  2016cites this paper
• New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.

  2016cites this paper
• Synthesis and evaluation of original bioisosteres of bacterial type IIA topoisomerases inhibitors

  2016cites this paper
• Carbazole-based salicylaldimine difluoroboron complex with crystallization-induced emission enhancement and reversible piezofluorochromism characteristics

  2016cites this paper
• Identifying selective ligands for glutaredoxin proteins with fragment based drug design approach and optimization of the bacterial selective hits

  2016cites this paper
• Nanoscale Engineering of Designer Cellulosomes

  2016cites this paper
• A DNA topoisomerase VI–like complex initiates meiotic recombination

  2016cites this paper
• Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914).

  2015cites this paper
• Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3).

  2015cites this paper
• Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.

  2015cites this paper
• Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases

  2015cites this paper
• Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding.

  2015cites this paper
• Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4).

  2015cites this paper
• High In Vitro Susceptibility to the Novel Spiropyrimidinetrione ETX0914 (AZD0914) among 873 Contemporary Clinical Neisseria gonorrhoeae Isolates from 21 European Countries from 2012 to 2014

  2015cites this paper
• Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram positive activity and improved safety profile.

  2015cites this paper
• Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).

  2015cites this paper
• Corrigendum: Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases

  2015cites this paper
• Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.

  2015cites this paper
• N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation.

  2015cites this paper
• Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).

  2015cites this paper
• Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae

  2015cites this paper
• Strukturbasierte Leitstruktursuche ATP-kompetitiver Inhibitoren der Gyrase Untereinheit B

  2015cites this paper
• Catalytic behavior of metal-organic frameworks and zeolites: Rationalization and comparative analysis

  2015cites this paper
• A novel ultrasound-sensitive mechanofluorochromic AIE-compound with remarkable blue-shifting and enhanced emission

  2014cites this paper
• Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase.

  2014cites this paper
• Gyramides Prevent Bacterial Growth by Inhibiting DNA Gyrase and Altering Chromosome Topology

  2014cites this paper
• Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization.

  2014cites this paper
• High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea

  2014cites this paper
• Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents.

  2014cites this paper
• Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.

  2014cites this paper